Marker Therapeutics annual capital expenditures (capex)
2017
2018
2019
2021
2022
Marker Therapeutics Capital Expenditures (CapEx) Growth & History (MRKR)
Marker Therapeutics's capital expenditures (capex) was $4.9M for fiscal 2022.
View full Marker Therapeutics company overviewMarker Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-12-31 | $4.9M | $1.8M | +57.93% |
| 2021 | 2021-12-31 | $3.1M | — | — |
| 2019 | 2019-12-31 | $374,983 | $227,315 | +153.94% |
| 2018 | 2018-12-31 | $147,668 | $147,668 | — |
| 2017 | 2017-12-31 | $0 | — | — |
Marker Therapeutics quarterly capital expenditures (capex)
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2020 | 2020-06-30 | $1.3M | $1.2M | +1480.43% |
| Q1 2020 | 2020-03-31 | $99,821 | −$123,305 | −55.26% |
| Q4 2019 | 2019-12-31 | $12,862 | −$134,806 | −91.29% |
| Q3 2019 | 2019-09-30 | $56,739 | $56,739 | — |
| Q2 2019 | 2019-06-30 | $82,256 | $82,256 | — |
| Q1 2019 | 2019-03-31 | $223,126 | $223,126 | — |
| Q4 2018 | 2018-12-31 | $147,668 | — | — |
| Q3 2018 | 2018-09-30 | $0 | — | — |
| Q2 2018 | 2018-06-30 | $0 | — | — |
| Q1 2018 | 2018-03-31 | $0 | — | — |
Marker Therapeutics capital expenditures (capex) trends
Over the last five fiscal years, Marker Therapeutics's capital expenditures (capex) increased from $0 to $4.9M, a change of $4.9M. The latest reported quarter, Q2 2020, shows $1.3M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Marker Therapeutics source filings ↗